drugset / Trial / NCT05279898

Perioperative Multimodal General AnesTHesia Focusing on Specific CNS Targets in Patients Undergoing carDiac surgERies

NCT05279898

Completed 70 enrolled Beth Israel Deaconess Medical Center
RandomizedParallel-groupSingle-blindPrevention

Summary

In the PATHFINDER 2 trial, the study investigators will test the intraoperative EEG-guided multimodal general anesthesia (MMGA) management strategy in combination with a postoperative protocolized analgesic approach to: 1. reduce the incidence of perioperative neurocognitive dysfunction in cardiac surgical patients 2. ensure hemodynamic stability and decrease use of vasopressors in the operating rooms 3. reduce pain and opioid consumption postoperatively

Timeline

Start
2023-02-28
Primary completion
2024-06-30
Completion
2024-12-31

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 0.2 ug/kg
Subject Dexmedetomidine Other / unclassified 0.4 ug/kg
Subject Dexmedetomidine Other / unclassified 0.5 ug/kg
Subject Dexmedetomidine Other / unclassified 1.4 ug/kg
Subject Ketamine Small molecule 0.1 mg/kg
Subject Ketamine Small molecule 0.2 mg/kg
Subject Propofol Small molecule 15 ug/kg
Subject Propofol Small molecule 200 ug/kg
Subject Remifentanil Small molecule 0.05 ug/kg
Subject Remifentanil Small molecule 0.4 ug/kg
Subject Rocuronium Other / unclassified
Subject Ropivacaine Other / unclassified 0.2 %
Subject Ropivacaine Other / unclassified 20 ml

Indications